Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | Apixaban may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Dabigatran etexilate | Dabigatran etexilate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Dasatinib | The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with 4-hydroxycoumarin. |
| Deferasirox | The risk or severity of gastrointestinal bleeding can be increased when 4-hydroxycoumarin is combined with Deferasirox. |
| Ursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Hyodeoxycholic Acid. |
| Edoxaban | The risk or severity of bleeding can be increased when Edoxaban is combined with 4-hydroxycoumarin. |
| Ibrutinib | The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with 4-hydroxycoumarin. |
| Obinutuzumab | The risk or severity of bleeding and hemorrhage can be increased when 4-hydroxycoumarin is combined with Obinutuzumab. |
| Rivaroxaban | 4-hydroxycoumarin may increase the anticoagulant activities of Rivaroxaban. |
| Sugammadex | The risk or severity of bleeding and hemorrhage can be increased when 4-hydroxycoumarin is combined with Sugammadex. |
| Tibolone | Tibolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Tipranavir | The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with 4-hydroxycoumarin. |
| Urokinase | Urokinase may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Vitamin E | Vitamin E may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Vorapaxar | The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with 4-hydroxycoumarin. |
| Gemcitabine | The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Gemcitabine. |
| Flunisolide | Flunisolide may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Beclomethasone dipropionate | Beclomethasone dipropionate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Betamethasone | Betamethasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluticasone propionate | Fluticasone propionate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluocinolone acetonide | Fluocinolone acetonide may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisone | Prednisone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fludrocortisone | Fludrocortisone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Hydrocortisone | Hydrocortisone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisolone | Prednisolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Methylprednisolone | Methylprednisolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Trilostane | Trilostane may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Budesonide | Budesonide may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Dexamethasone | Dexamethasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Corticotropin | Corticotropin may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Cortisone acetate | Cortisone acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Paramethasone | Paramethasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Ciclesonide | Ciclesonide may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Aldosterone | Aldosterone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluticasone furoate | Fluticasone furoate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluprednidene | Fluprednidene may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Tixocortol | Tixocortol may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluprednisolone | Fluprednisolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Meprednisone | Meprednisone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Dexamethasone isonicotinate | Dexamethasone isonicotinate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Melengestrol | Melengestrol may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Deflazacort | Deflazacort may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Cortivazol | Cortivazol may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednylidene | Prednylidene may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluocortin | Fluocortin may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluperolone | Fluperolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Cloprednol | Cloprednol may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluclorolone | Fluclorolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluticasone | Fluticasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Mometasone furoate | Mometasone furoate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Hydrocortisone acetate | Hydrocortisone acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Hydrocortisone cypionate | Hydrocortisone cypionate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Hydrocortisone succinate | Hydrocortisone succinate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisolone phosphate | Prednisolone phosphate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisolone hemisuccinate | Prednisolone hemisuccinate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Methylprednisolone hemisuccinate | Methylprednisolone hemisuccinate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisone acetate | Prednisone acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Clocortolone acetate | Clocortolone acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Melengestrol acetate | Melengestrol acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Betamethasone phosphate | Betamethasone phosphate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Cortisone | Cortisone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Clobetasol propionate | Clobetasol propionate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluocinonide | Fluocinonide may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Hydrocortisone butyrate | Hydrocortisone butyrate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Desoximetasone | Desoximetasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Mometasone | Mometasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluocortolone | Fluocortolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Prednisolone acetate | Prednisolone acetate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Fluorometholone | Fluorometholone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Difluocortolone | Difluocortolone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Flumethasone | Flumethasone may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Methylprednisolone aceponate | Methylprednisolone aceponate may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Erlotinib | The serum concentration of 4-hydroxycoumarin can be increased when it is combined with Erlotinib. |
| Acetaminophen | Acetaminophen may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Allopurinol | The risk or severity of bleeding can be increased when Allopurinol is combined with 4-hydroxycoumarin. |
| Azathioprine | The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Azathioprine. |
| Chloral hydrate | The protein binding of 4-hydroxycoumarin can be decreased when combined with Chloral hydrate. |
| Methylphenidate | The metabolism of 4-hydroxycoumarin can be decreased when combined with Methylphenidate. |
| Disulfiram | Disulfiram may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Etacrynic acid | The protein binding of 4-hydroxycoumarin can be decreased when combined with Etacrynic acid. |
| Ethotoin | The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Ethotoin. |
| Etoposide | The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Etoposide. |
| Exenatide | Exenatide can cause an increase in the absorption of 4-hydroxycoumarin resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Gefitinib | Gefitinib may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Ginkgo biloba | Ginkgo biloba may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Glutethimide | The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Glutethimide. |
| Ifosfamide | The risk or severity of bleeding can be increased when Ifosfamide is combined with 4-hydroxycoumarin. |
| Leflunomide | The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Leflunomide. |